SESSION TITLE: Critical Care: ARDS/ALI
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: Acute lung injury (ALI) is characterized by excessive inflammatory responses and oxidative injury in lung tissue and the anti-inflammatory or anti-oxidative agent is proposed to be a therapeutic drugs for ALI. Eriodictyol has been reported to have anti-oxidative and anti-inflammatory activity in vitro assay. In this study, we investigated the effect of eriodictyol on the LPS-induced acute lung injury in mice model.